IBDEI0JC ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8702,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
;;^UTILITY(U,$J,358.3,8702,1,4,0)
;;=4^D57.20
;;^UTILITY(U,$J,358.3,8702,2)
;;=^330080
;;^UTILITY(U,$J,358.3,8703,0)
;;=D57.211^^39^401^196
;;^UTILITY(U,$J,358.3,8703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8703,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
;;^UTILITY(U,$J,358.3,8703,1,4,0)
;;=4^D57.211
;;^UTILITY(U,$J,358.3,8703,2)
;;=^5002310
;;^UTILITY(U,$J,358.3,8704,0)
;;=D57.212^^39^401^200
;;^UTILITY(U,$J,358.3,8704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8704,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,8704,1,4,0)
;;=4^D57.212
;;^UTILITY(U,$J,358.3,8704,2)
;;=^5002311
;;^UTILITY(U,$J,358.3,8705,0)
;;=D57.213^^39^401^197
;;^UTILITY(U,$J,358.3,8705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8705,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
;;^UTILITY(U,$J,358.3,8705,1,4,0)
;;=4^D57.213
;;^UTILITY(U,$J,358.3,8705,2)
;;=^5159080
;;^UTILITY(U,$J,358.3,8706,0)
;;=D57.218^^39^401^198
;;^UTILITY(U,$J,358.3,8706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8706,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
;;^UTILITY(U,$J,358.3,8706,1,4,0)
;;=4^D57.218
;;^UTILITY(U,$J,358.3,8706,2)
;;=^5159081
;;^UTILITY(U,$J,358.3,8707,0)
;;=D57.219^^39^401^199
;;^UTILITY(U,$J,358.3,8707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8707,1,3,0)
;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
;;^UTILITY(U,$J,358.3,8707,1,4,0)
;;=4^D57.219
;;^UTILITY(U,$J,358.3,8707,2)
;;=^5002312
;;^UTILITY(U,$J,358.3,8708,0)
;;=D57.3^^39^401^195
;;^UTILITY(U,$J,358.3,8708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8708,1,3,0)
;;=3^Sickle-Cell Trait
;;^UTILITY(U,$J,358.3,8708,1,4,0)
;;=4^D57.3
;;^UTILITY(U,$J,358.3,8708,2)
;;=^5002313
;;^UTILITY(U,$J,358.3,8709,0)
;;=D57.40^^39^401^192
;;^UTILITY(U,$J,358.3,8709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8709,1,3,0)
;;=3^Sickle-Cell Thalassemia w/o Crisis
;;^UTILITY(U,$J,358.3,8709,1,4,0)
;;=4^D57.40
;;^UTILITY(U,$J,358.3,8709,2)
;;=^329908
;;^UTILITY(U,$J,358.3,8710,0)
;;=D57.411^^39^401^193
;;^UTILITY(U,$J,358.3,8710,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8710,1,3,0)
;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
;;^UTILITY(U,$J,358.3,8710,1,4,0)
;;=4^D57.411
;;^UTILITY(U,$J,358.3,8710,2)
;;=^5002314
;;^UTILITY(U,$J,358.3,8711,0)
;;=D57.412^^39^401^194
;;^UTILITY(U,$J,358.3,8711,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8711,1,3,0)
;;=3^Sickle-Cell Thalassemia,Unspec w/ Splenic Sequestration
;;^UTILITY(U,$J,358.3,8711,1,4,0)
;;=4^D57.412
;;^UTILITY(U,$J,358.3,8711,2)
;;=^5002315
;;^UTILITY(U,$J,358.3,8712,0)
;;=M31.10^^39^401^215
;;^UTILITY(U,$J,358.3,8712,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8712,1,3,0)
;;=3^Thrombotic Microangiopathy,Unspec
;;^UTILITY(U,$J,358.3,8712,1,4,0)
;;=4^M31.10
;;^UTILITY(U,$J,358.3,8712,2)
;;=^5161189
;;^UTILITY(U,$J,358.3,8713,0)
;;=Z85.818^^39^402^86
;;^UTILITY(U,$J,358.3,8713,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8713,1,3,0)
;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
;;^UTILITY(U,$J,358.3,8713,1,4,0)
;;=4^Z85.818
;;^UTILITY(U,$J,358.3,8713,2)
;;=^5063439
;;^UTILITY(U,$J,358.3,8714,0)
;;=Z85.819^^39^402^87
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0JC 3786 printed Nov 22, 2024@17:00 Page 2
IBDEI0JC ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8702,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,8702,1,3,0)
+4 ;;=3^Sickle-Cell/Hb-C Disease w/o Crisis
+5 ;;^UTILITY(U,$J,358.3,8702,1,4,0)
+6 ;;=4^D57.20
+7 ;;^UTILITY(U,$J,358.3,8702,2)
+8 ;;=^330080
+9 ;;^UTILITY(U,$J,358.3,8703,0)
+10 ;;=D57.211^^39^401^196
+11 ;;^UTILITY(U,$J,358.3,8703,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,8703,1,3,0)
+14 ;;=3^Sickle-Cell/Hb-C Disease w/ Acute Chest Syndrome
+15 ;;^UTILITY(U,$J,358.3,8703,1,4,0)
+16 ;;=4^D57.211
+17 ;;^UTILITY(U,$J,358.3,8703,2)
+18 ;;=^5002310
+19 ;;^UTILITY(U,$J,358.3,8704,0)
+20 ;;=D57.212^^39^401^200
+21 ;;^UTILITY(U,$J,358.3,8704,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,8704,1,3,0)
+24 ;;=3^Sickle-Cell/Hb-C Disease w/ Splenic Sequestration
+25 ;;^UTILITY(U,$J,358.3,8704,1,4,0)
+26 ;;=4^D57.212
+27 ;;^UTILITY(U,$J,358.3,8704,2)
+28 ;;=^5002311
+29 ;;^UTILITY(U,$J,358.3,8705,0)
+30 ;;=D57.213^^39^401^197
+31 ;;^UTILITY(U,$J,358.3,8705,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,8705,1,3,0)
+34 ;;=3^Sickle-Cell/Hb-C Disease w/ Cerebral Vascular Involvement
+35 ;;^UTILITY(U,$J,358.3,8705,1,4,0)
+36 ;;=4^D57.213
+37 ;;^UTILITY(U,$J,358.3,8705,2)
+38 ;;=^5159080
+39 ;;^UTILITY(U,$J,358.3,8706,0)
+40 ;;=D57.218^^39^401^198
+41 ;;^UTILITY(U,$J,358.3,8706,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,8706,1,3,0)
+44 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis w/ Oth Complication
+45 ;;^UTILITY(U,$J,358.3,8706,1,4,0)
+46 ;;=4^D57.218
+47 ;;^UTILITY(U,$J,358.3,8706,2)
+48 ;;=^5159081
+49 ;;^UTILITY(U,$J,358.3,8707,0)
+50 ;;=D57.219^^39^401^199
+51 ;;^UTILITY(U,$J,358.3,8707,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,8707,1,3,0)
+54 ;;=3^Sickle-Cell/Hb-C Disease w/ Crisis,Unspec
+55 ;;^UTILITY(U,$J,358.3,8707,1,4,0)
+56 ;;=4^D57.219
+57 ;;^UTILITY(U,$J,358.3,8707,2)
+58 ;;=^5002312
+59 ;;^UTILITY(U,$J,358.3,8708,0)
+60 ;;=D57.3^^39^401^195
+61 ;;^UTILITY(U,$J,358.3,8708,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,8708,1,3,0)
+64 ;;=3^Sickle-Cell Trait
+65 ;;^UTILITY(U,$J,358.3,8708,1,4,0)
+66 ;;=4^D57.3
+67 ;;^UTILITY(U,$J,358.3,8708,2)
+68 ;;=^5002313
+69 ;;^UTILITY(U,$J,358.3,8709,0)
+70 ;;=D57.40^^39^401^192
+71 ;;^UTILITY(U,$J,358.3,8709,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,8709,1,3,0)
+74 ;;=3^Sickle-Cell Thalassemia w/o Crisis
+75 ;;^UTILITY(U,$J,358.3,8709,1,4,0)
+76 ;;=4^D57.40
+77 ;;^UTILITY(U,$J,358.3,8709,2)
+78 ;;=^329908
+79 ;;^UTILITY(U,$J,358.3,8710,0)
+80 ;;=D57.411^^39^401^193
+81 ;;^UTILITY(U,$J,358.3,8710,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,8710,1,3,0)
+84 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Acute Chest Syndrome
+85 ;;^UTILITY(U,$J,358.3,8710,1,4,0)
+86 ;;=4^D57.411
+87 ;;^UTILITY(U,$J,358.3,8710,2)
+88 ;;=^5002314
+89 ;;^UTILITY(U,$J,358.3,8711,0)
+90 ;;=D57.412^^39^401^194
+91 ;;^UTILITY(U,$J,358.3,8711,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,8711,1,3,0)
+94 ;;=3^Sickle-Cell Thalassemia,Unspec w/ Splenic Sequestration
+95 ;;^UTILITY(U,$J,358.3,8711,1,4,0)
+96 ;;=4^D57.412
+97 ;;^UTILITY(U,$J,358.3,8711,2)
+98 ;;=^5002315
+99 ;;^UTILITY(U,$J,358.3,8712,0)
+100 ;;=M31.10^^39^401^215
+101 ;;^UTILITY(U,$J,358.3,8712,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,8712,1,3,0)
+104 ;;=3^Thrombotic Microangiopathy,Unspec
+105 ;;^UTILITY(U,$J,358.3,8712,1,4,0)
+106 ;;=4^M31.10
+107 ;;^UTILITY(U,$J,358.3,8712,2)
+108 ;;=^5161189
+109 ;;^UTILITY(U,$J,358.3,8713,0)
+110 ;;=Z85.818^^39^402^86
+111 ;;^UTILITY(U,$J,358.3,8713,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,8713,1,3,0)
+114 ;;=3^Personal Hx of Malig Neop of Lip,Oral Cavity & Pharynx
+115 ;;^UTILITY(U,$J,358.3,8713,1,4,0)
+116 ;;=4^Z85.818
+117 ;;^UTILITY(U,$J,358.3,8713,2)
+118 ;;=^5063439
+119 ;;^UTILITY(U,$J,358.3,8714,0)
+120 ;;=Z85.819^^39^402^87
